HAP Trading’s Intersect ENT, Inc XENT Stock Holding History

HAP Trading’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-34,988	Closed	-$956K	–	2987
2021 Q4	$956K	Buy	34,988 +20,000	+133%	+$542K	0.03%	488
2021 Q3	$408K	Buy	+14,988	New	+$371K	0.01%	737

Other funds holding XENT

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MAM

Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HAP Trading's XENT Position: Q1 2022 in Review

HAP Trading sold out of Intersect ENT, Inc (XENT) in Q1 2022, closing a stake of 34,988 shares — an estimated $956K sold.

HAP Trading first reported a position in XENT in Q3 2021 and held it in 2 quarters. The position peaked at $956K in Q4 2021. 131 funds tracked by Wall St. Rank hold XENT as of Q1 2022.

HAP Trading reported no remaining Intersect ENT, Inc position as of Q1 2022 after selling out during the quarter.
HAP Trading sold 34,988 Intersect ENT, Inc shares in Q1 2022, an estimated $956K.
HAP Trading first reported a position in Intersect ENT, Inc in Q3 2021 and held it in 2 quarters.
HAP Trading's Intersect ENT, Inc position peaked at $956K in Q4 2021.
131 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2022.

Based on HAP Trading's 13F filing for Q1 2022, filed 12 May 2022.